Attention mental healthcare providers! Exciting news in the world of mental health therapy. On December 12, 2023, MAPS Public Benefit Corporation filed the first New Drug Application for any psychedelic-assisted therapy. If approved, MDMA-assisted therapy would be the first psychedelic-assisted therapy approved for PTSD. This would require the DEA to reschedule MDMA, making it available for prescription medical use. Learn more at MAPS PBC Announces Submission of New Drug Application to the FDA for MDMA-Assisted Therapy for PTSD | MAPS Public Benefit Corporation (mapsbcorp.com)